The trivalent influenza vaccine used in the last 25 years contains one B strain, with approximately 31% of B strain disease coverage over the last 10 years. Fluarix quadrivalent vaccine, containing two A and two B strains, combines the components of two existing trivalent vaccines to prevent ...
16. (2023) "Product Information. Influenza (Split Virion, Inactivated) Vaccine (influenza vaccine)." Sanofi Pasteur 17. (2023) "Product Information. Cell-Based Quadrivalent Influenza Vaccine (influenza vaccine)." Seqirus UK Ltd 18. (2023) "Product Information. Supemtek Quadrivalent (influenza vacci...
Over the past 30 years, two main influenza B strains have been circulating globally. The trivalent influenza vaccine used in the last 25 years contains one B strain, with approximately 31% of B strain disease coverage over the last 10 years. Fluarix quadrivalent vaccine, containing two A and ...
seasonal influenza (flu) virus subtypes A and B contained in the vaccine. This is the second GSK intramuscular quadrivalent influenza vaccineapprovedby the FDA. GSK'sFluarix Quadrivalentwas the first-ever intramuscular influenza vaccine approved by the FDA in December 2012 and is now shipping to ...
Faculty Opinions recommendation of Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised ... The FDA has named the vaccines that will be used against three strains of influenza that are considered most likely to cause the illness next...
通用名 inactivated split influenza vaccine/flulaval quadrivalent 通用名(中文) 流感病毒裂解疫苗/四价流感疫苗 企业名称 GlaxoSmithKline plc(葛兰素史克) 销售额(万元/RMB) 266544 销售额(原始) 215 货币单位(原始) 百万英镑 年份 2008 畅销药品数据分析 全球畅销药品销售数据分析 暂无权限!更多信息,升级...
Individuals were randomly assigned (2:2:1) to receive a single immunisation of either 1011 infectious units of VXA-A1.1 (a monovalent tablet vaccine) orally, a full human dose of quadrivalent inactivated influenza vaccine (IIV) via intramuscular injection, or matched placebo. Randomisation was ...
Adults and children aged >36 months received 0.5ml of the vaccine by intramuscular or deep subcutaneous injection. Children aged 6–35 months received 0.25ml; in some children not previously vaccinated or exposed to influenza, a second dose was given 4 weeks later. Immunogenicity was determined ...
McKeage K. Inactivated quadrivalent split-virus season- al influenza vaccine (Fluarix(R) quadrivalent): a review of its use in the prevention of disease caused by influen- za A and B. Drugs 2013;73:1587-94.McKeage K. Inactivated quadrivalent split-virus seasonal influenza vaccine (Fluarix(R...
The article offers information on the approval of a vaccine Fluarix Quadrivalent OK'd from the company GlaxoSmithKline for the immunization of patients to prevent disease caused by seasonal influenza virus subtypes A.Monthly Prescribing Reference